Toliodium

Toliodium

SCHEMBL2898696

Cc1ccc([I+]c2ccc(C)cc2)cc1.O=S(=O)([O-])C(F)(F)F

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR3 P46089 2/20 0.44
KCNH2 Q12809 2/20 0.43
TLR9 Q9NR96 1/20 0.42
GAA P10253 2/20 0.41
CA1 P00915 3/20 0.41
CA2 P00918 3/20 0.41
CA5A P35218 2/20 0.41
CA9 Q16790 2/20 0.41
CA12 O43570 1/20 0.39
CA3 P07451 1/20 0.39
CA6 P23280 1/20 0.39
CA7 P43166 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.36
ACHE P22303 3/20 0.36
ALDH1A1 P00352 3/20 0.35
MMP1 P03956 1/20 0.35
MMP2 P08253 1/20 0.35
MMP9 P14780 1/20 0.35
MMP8 P22894 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoromethanesulfonic Acid SCHEMBL2851342 0.93 GPR3 (0.47) GPR3KCNH2TLR9GAACA1
Trifluoromethanesulfonic Acid SCHEMBL4643916 0.86 KCNH2 (0.44) GPR3KCNH2TLR9GAACA1
Trifluoromethanesulfonic Acid SCHEMBL29462458 0.85 RAPGEF4 (0.41) GPR3KCNH2TLR9GAACA1
Toliodium SCHEMBL7573696 0.83 TLR9 (0.48) TLR9GAACA1CA2CA5A
Toliodium SCHEMBL2895493 0.83 TLR9 (0.39) GPR3KCNH2TLR9GAACA1
SCHEMBL3762393 0.82 TSHR (0.44) GAACA1CA2CA5ACA9
Trifluoromethanesulfonic Acid SCHEMBL4644616 0.82 KCNH2 (0.44) GPR3KCNH2TLR9CA1CA2
Trifluoromethanesulfonic Acid SCHEMBL4643748 0.82 HTT (0.40) GPR3KCNH2CA1CA2CA9
Trifluoromethanesulfonic Acid SCHEMBL4643958 0.82 MLYCD (0.37) GPR3KCNH2TLR9CA1CA2
Trifluoromethanesulfonic Acid SCHEMBL504034 0.82 GPR3 (0.40) GPR3CA1CA2ACHEALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 55 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119874480-A Purification method of high-purity di-p-tolylidine triflate 苏州威迈芯材半导体有限公司 2025-04-25 CN claimed
US-4968581-A High resolution photoresist of imide containing polymers HOECHST CELANESE CORPORATION (US) 1990-11-06 US claimed
US-4912018-A High resolution photoresist based on imide containing polymers HOECHST CELANESE CORPORATION (US) 1990-03-27 US claimed
US-4837124-A High resolution photoresist of imide containing polymers HOECHST CELANESE CORPORATION (US) 1989-06-06 US claimed
CN-119874480-A Purification method of high-purity di-p-tolylidine triflate 苏州威迈芯材半导体有限公司 2025-04-25 CN disclosed
CN-119874480-A Purification method of high-purity di-p-tolylidine triflate 苏州威迈芯材半导体有限公司 2025-04-25 CN disclosed
US-20250042854-A1 IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF ECOLE NAT SUPERIEURE DE CHIMIE DE RENNES (FR) 2025-02-06 US disclosed
CN-111410603-B Benzanthrone derivative, preparation method thereof and application thereof in functional pigment 上海甘田光学材料有限公司 2022-12-16 CN disclosed
EP-1253470-B1 Radiation-sensitive resin composition JSR CORP (JP) 2010-06-16 EP disclosed
EP-1238972-B1 Novel carbazole derivative and chemically amplified radiation-sensitive resin composition JSR CORP (JP) 2009-12-16 EP disclosed
EP-1270553-B1 Acid generator, sulfonic acid, sulfonic acid derivatives and radiation-sensitive resin composition JSR CORP (JP) 2009-11-18 EP disclosed
EP-1640804-B1 Positive-tone radiation-sensitive resin composition JSR CORP (JP) 2008-11-19 EP disclosed
EP-0813521-A1 ENERGY-ACTIVATABLE SALTS WITH FLUOROCARBON ANIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-12-29 EP disclosed
EP-0748201-A1 PASTE:PASTE GLASS IONOMER CEMENT SYSTEM AND METHOD MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-12-18 EP disclosed
WO-1996027584-A1 ENERGY-ACTIVATABLE SALTS WITH FLUOROCARBON ANIONS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-09-12 WO disclosed
US-5488147-A Diaryliodonium fluoroalkyl sulfonate salts and a method of making MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-01-30 US disclosed
EP-0693468-A2 Diaryliodonium fluoroalkyl sulphonate salts and a method of making them MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-01-24 EP disclosed
WO-1995022956-A1 PASTE:PASTE GLASS IONOMER CEMENT SYSTEM AND METHODS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1995-08-31 WO disclosed
US-5330836-A Couplers TEMPLE UNIVERSITY-OF THE COMMON COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 1994-07-19 US disclosed
WO-1994005730-A1 FUNCTIONALIZED SILICA PARTICLE AND USE THEREOF FOR CROSS-LINKING SILICONES TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 1994-03-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250042854-A1 IMINIUM SALTS WITH A BARRALENE RING, CORRESPONDING RUTHENIUM COMPLEXES, AND USES THEREOF SQLE, SYMPK, FDFT1 GPR3 3031/4885KCNH2 1942/4885TLR9 2865/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.